Nuvation Bio Inc.
Substituted 1,6-dihydropyridinones and 1,2-dihydroisoquinolinones as bet inhibitors
Last updated:
Abstract:
Novel bromodomain and extraterminal domain (BET) inhibitors contanining substituted 2-pyridones and therapeutic methods of treating conditions and diseases using these novel BET inhibitors are provided.
Status:
Grant
Type:
Utility
Filling date:
30 Oct 2019
Issue date:
7 Dec 2021